Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 75 Clinical Trials
ID/Name Source Type
[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)
NCT02621606 clinicaltrials.gov Clinical Trial
[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)
NCT02562989 clinicaltrials.gov Clinical Trial
18F-AV-1451 Autopsy Study
NCT02516046 clinicaltrials.gov Clinical Trial
18F-AV-1451 High Resolution Autopsy Study
NCT02350634 clinicaltrials.gov Clinical Trial
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
NCT03316898 clinicaltrials.gov Clinical Trial
A Non-drug Methods Study in Participants With Alzheimer's Disease
NCT01459016 clinicaltrials.gov Clinical Trial
A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)
NCT02423122 clinicaltrials.gov Clinical Trial
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
NCT01886820 clinicaltrials.gov Clinical Trial
A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
NCT00702143 clinicaltrials.gov Clinical Trial
A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
NCT01662882 clinicaltrials.gov Clinical Trial